메뉴 건너뛰기




Volumn 97, Issue 3, 2013, Pages 306-312

Multiple myeloma-initiating cells

Author keywords

CD138; Multiple myeloma; Progenitor cell; Stem cell; Xenotransplant

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER CELL; ENGRAFTMENT; HUMAN; IN VIVO STUDY; MULTIPLE MYELOMA; NONHUMAN; PLASMA CELL; SCID MOUSE; STEM CELL; TUMOR MICROENVIRONMENT; XENOGRAFT; ANIMAL; BONE MARROW; CANCER TRANSPLANTATION; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; REVIEW;

EID: 84887601514     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1293-0     Document Type: Article
Times cited : (27)

References (33)
  • 2
    • 42449114035 scopus 로고    scopus 로고
    • Multiple myeloma
    • Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111: 2962-72.
    • (2008) Blood , vol.111 , pp. 2962-2972
    • Kyle, R.A.1    Rajkumar, S.V.2
  • 3
    • 85027950818 scopus 로고    scopus 로고
    • Update on risk stratification and treatment of newly diagnosed multiple myeloma
    • Kapoor P, Rajkumar SV. Update on risk stratification and treatment of newly diagnosed multiple myeloma. Int J Hematol. 2011;94(4):310-20.
    • (2011) Int J Hematol , vol.94 , Issue.4 , pp. 310-320
    • Kapoor, P.1    Rajkumar, S.V.2
  • 4
    • 0026786675 scopus 로고
    • Evidence that multiple myeloma ig heavy chain vdj genes contain somatic mutations but show no intraclonal variation
    • Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992;80:2326-35.
    • (1992) Blood , vol.80 , pp. 2326-2335
    • Bakkus, M.H.1    Heirman, C.2    Van Riet, I.3    Van Camp, B.4    Thielemans, K.5
  • 5
    • 0029077309 scopus 로고
    • Myeloma ig heavy chain v region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity
    • Vescio RA, Cao J, Hong CH, et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol. 1995; 155:2487-97.
    • (1995) J Immunol , vol.155 , pp. 2487-2497
    • Vescio, R.A.1    Cao, J.2    Hong, C.H.3
  • 6
    • 0030614775 scopus 로고    scopus 로고
    • Myeloma Vl and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells
    • Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood. 1997;89:219-26.
    • (1997) Blood , vol.89 , pp. 219-226
    • Sahota, S.S.1    Leo, R.2    Hamblin, T.J.3    Stevenson, F.K.4
  • 7
    • 0026552179 scopus 로고
    • Monoclonal circulating b cells in multiple myeloma, A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules
    • Pilarski LM, Jensen GS. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am. 1992;6:297-322.
    • (1992) Hematol Oncol Clin North Am , vol.6 , pp. 297-322
    • Pilarski, L.M.1    Jensen, G.S.2
  • 8
    • 0028908877 scopus 로고
    • In multiple myeloma, clonotypic b lymphocytes are detectable among CD19? Peripheral blood cells expressing CD38, CD56, and monotypic ig light chain
    • Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19? peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood. 1995;85:436-47.
    • (1995) Blood , vol.85 , pp. 436-447
    • Bergsagel, P.L.1    Smith, A.M.2    Szczepek, A.3    Mant, M.J.4    Belch, A.R.5    Pilarski, L.M.6
  • 9
    • 0030049654 scopus 로고    scopus 로고
    • Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of b cells
    • Chen BJ, Epstein J. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood. 1996;87: 1972-6.
    • (1996) Blood , vol.87 , pp. 1972-1976
    • Chen, B.J.1    Epstein, J.2
  • 10
    • 0036240724 scopus 로고    scopus 로고
    • The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment
    • Rasmussen T, Jensen L, Johnsen HE. The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment. Leuk Lymphoma. 2002;43:1075-7.
    • (2002) Leuk Lymphoma , vol.43 , pp. 1075-1077
    • Rasmussen, T.1    Jensen, L.2    Johnsen, H.E.3
  • 11
    • 0036191321 scopus 로고    scopus 로고
    • Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice
    • Pilarski LM, Seeberger K, Coupland RW, et al. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice. Exp Hematol. 2002;30:221-8.
    • (2002) Exp Hematol , vol.30 , pp. 221-228
    • Pilarski, L.M.1    Seeberger, K.2    Coupland, R.W.3
  • 12
    • 0034142369 scopus 로고    scopus 로고
    • Myeloma progenitors in the blood of patients with aggressive or minimal disease: Engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice
    • Pilarski LM, Hipperson G, Seeberger K, Pruski E, Coupland RW, Belch AR. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood. 2000;95:1056-65.
    • (2000) Blood , vol.95 , pp. 1056-1065
    • Pilarski, L.M.1    Hipperson, G.2    Seeberger, K.3    Pruski, E.4    Coupland, R.W.5    Belch, A.R.6
  • 13
    • 1542283717 scopus 로고    scopus 로고
    • Characterization of clonogenic multiple myeloma cells
    • Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004;103:2332-6.
    • (2004) Blood , vol.103 , pp. 2332-2336
    • Matsui, W.1    Huff, C.A.2    Wang, Q.3
  • 14
    • 38549132452 scopus 로고    scopus 로고
    • Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance
    • Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008;68:190-7.
    • (2008) Cancer Res , vol.68 , pp. 190-197
    • Matsui, W.1    Wang, Q.2    Barber, J.P.3
  • 16
    • 84865862858 scopus 로고    scopus 로고
    • CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
    • Hosen N, Matsuoka Y, Kishida S, et al. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. Leukemia. 2012;26:2135-41.
    • (2012) Leukemia , vol.26 , pp. 2135-2141
    • Hosen, N.1    Matsuoka, Y.2    Kishida, S.3
  • 17
    • 84871238560 scopus 로고    scopus 로고
    • CD19(-)CD45(low/-)CD38(high)/CD138 plasma cells enrich for human tumorigenic myeloma cells
    • Kim D, Park CY, Medeiros BC, Weissman IL. CD19(- )CD45(low/-)CD38(high)/ CD138 plasma cells enrich for human tumorigenic myeloma cells. Leukemia. 2012;26(12):2530-7.
    • (2012) Leukemia , vol.26 , Issue.12 , pp. 2530-2537
    • Kim, D.1    Park, C.Y.2    Medeiros, B.C.3    Weissman, I.L.4
  • 18
    • 0032532608 scopus 로고    scopus 로고
    • Primary myeloma cells growing in SCID-HU mice: A model for studying the biology and treatment of myeloma and its manifestations
    • Yaccoby S, Barlogie B, Epstein J. Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations. Blood. 1998;92:2908-13.
    • (1998) Blood , vol.92 , pp. 2908-2913
    • Yaccoby, S.1    Barlogie, B.2    Epstein, J.3
  • 19
    • 8844264524 scopus 로고    scopus 로고
    • The SCID-RAB model: A novel in vivo system for primary human myeloma demonstrating growth of CD138- expressing malignant cells
    • Yata K, Yaccoby S. The SCID-rab model: A novel in vivo system for primary human myeloma demonstrating growth of CD138- expressing malignant cells. Leukemia. 2004;18:1891-7.
    • (2004) Leukemia , vol.18 , pp. 1891-1897
    • Yata, K.1    Yaccoby, S.2
  • 20
    • 84865011312 scopus 로고    scopus 로고
    • Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
    • Kawano Y, Fujiwara S, Wada N, et al. Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide. Int J Oncol. 2012;41(3):876-84.
    • (2012) Int J Oncol , vol.41 , Issue.3 , pp. 876-884
    • Kawano, Y.1    Fujiwara, S.2    Wada, N.3
  • 21
    • 77953229444 scopus 로고    scopus 로고
    • Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells
    • Fuhler GM, Baanstra M, Chesik D, et al. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells. Exp Cell Res. 2010;316: 1816-28.
    • (2010) Exp Cell Res , vol.316 , pp. 1816-1828
    • Fuhler, G.M.1    Baanstra, M.2    Chesik, D.3
  • 22
    • 79955974540 scopus 로고    scopus 로고
    • Lenalidomide targets clonogenic side population in multiple myeloma: Pathophysiologic and clinical implications
    • Jakubikova J, Adamia S, Kost-Alimova M, et al. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood. 2011;117:4409-19.
    • (2011) Blood , vol.117 , pp. 4409-4419
    • Jakubikova, J.1    Adamia, S.2    Kost-Alimova, M.3
  • 23
    • 34547106018 scopus 로고    scopus 로고
    • Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
    • Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585-98.
    • (2007) Nat Rev Cancer , vol.7 , Issue.8 , pp. 585-598
    • Hideshima, T.1    Mitsiades, C.2    Tonon, G.3    Richardson, P.G.4    Anderson, K.C.5
  • 24
    • 85027940706 scopus 로고    scopus 로고
    • Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
    • Abe M. Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma. Int J Hematol. 2011;94(4):334-43.
    • (2011) Int J Hematol , vol.94 , Issue.4 , pp. 334-343
    • Abe, M.1
  • 25
    • 84856693203 scopus 로고    scopus 로고
    • Neovascular niche for human myeloma cells in immunodeficient mouse bone
    • Iriuchishima H, Takubo K, Miyakawa Y, et al. Neovascular niche for human myeloma cells in immunodeficient mouse bone. PLoS One. 2012;7(2):e30557.
    • (2012) PLoS One , vol.7 , Issue.2
    • Iriuchishima, H.1    Takubo, K.2    Miyakawa, Y.3
  • 26
    • 70349836514 scopus 로고    scopus 로고
    • Niche regulation of hematopoietic stem cells in the endosteum
    • Arai F, Yoshihara H, Hosokawa K, et al. Niche regulation of hematopoietic stem cells in the endosteum. Ann N Y Acad Sci. 2009;1176:36-46.
    • (2009) Ann N Y Acad Sci , vol.1176 , pp. 36-46
    • Arai, F.1    Yoshihara, H.2    Hosokawa, K.3
  • 27
    • 80051589767 scopus 로고    scopus 로고
    • Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia
    • Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20(2):246-59.
    • (2011) Cancer Cell , vol.20 , Issue.2 , pp. 246-259
    • Kikushige, Y.1    Ishikawa, F.2    Miyamoto, T.3
  • 28
    • 34247192972 scopus 로고    scopus 로고
    • Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
    • Peacock CD, Wang Q, Gesell GS, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA. 2007;104:4048-53.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 4048-4053
    • Peacock, C.D.1    Wang, Q.2    Gesell, G.S.3
  • 29
    • 41349095228 scopus 로고    scopus 로고
    • Inhibition of notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy
    • Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 2008;111: 2220-9.
    • (2008) Blood , vol.111 , pp. 2220-2229
    • Nefedova, Y.1    Sullivan, D.M.2    Bolick, S.C.3    Dalton, W.S.4    Gabrilovich, D.I.5
  • 30
    • 85027944452 scopus 로고    scopus 로고
    • Novel therapies in MM: From the aspect of preclinical studies
    • Hideshima T, Anderson KC. Novel therapies in MM: from the aspect of preclinical studies. Int J Hematol. 2011;94(4):344-54.
    • (2011) Int J Hematol , vol.94 , Issue.4 , pp. 344-354
    • Hideshima, T.1    Anderson, K.C.2
  • 31
    • 84863922801 scopus 로고    scopus 로고
    • CS1-directed monoclonal antibody therapy for multiple myeloma
    • Benson DM Jr, Byrd JC. CS1-directed monoclonal antibody therapy for multiple myeloma. J Clin Oncol. 2012;30(16): 2013-5.
    • (2012) J Clin Oncol , vol.30 , Issue.16 , pp. 2013-2015
    • Benson Jr., D.M.1    Byrd, J.C.2
  • 32
    • 79251570884 scopus 로고    scopus 로고
    • Daratumumab, A novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors
    • de Weers M, Tai YT, van der Veer MS, et al. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol. 2011;186(3):1840-8.
    • (2011) J Immunol , vol.186 , Issue.3 , pp. 1840-1848
    • De Weers, M.1    Tai, Y.T.2    Van Der Veer, M.S.3
  • 33
    • 84155195009 scopus 로고    scopus 로고
    • CD48 as a novel molecular target for antibody therapy in multiple myeloma
    • Hosen N, Ichihara H, Mugitani A, et al. CD48 as a novel molecular target for antibody therapy in multiple myeloma. Br J Haematol. 2011;156:213-24.
    • (2011) Br J Haematol , vol.156 , pp. 213-224
    • Hosen, N.1    Ichihara, H.2    Mugitani, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.